FABAD J. Pharm. Sci., 24, 125-127, 1999
WORLD CONGRESS of PHARMACY and PHARMACEUTICAL SCIENCES '99
59th International Congress of FIP.
Main theme: Facing Challenges and Achieving Success 5-10 September 1999, Barcelona - Spain
Provisional Programrne
09.00-17.00 Sunday, 5 September
Registration Council meeting
Monday, 6 September 09.00-17.00 Registration
Opening Ceremony Host Madsen Lecture Pharrnacy in Spain
Tuesday, 7 Septernber 09.00-12.00
Syrnposium l: Setting Specifications far Drug Sub- stances and Dosage Forms-Global Concept far Chemical and Biological Quality Characteristics.
Symposium 2: Challenges of Dietary Supplements (Vitamins and Botanicals) to Stan- dard Setting.
Symposium 3: Rational Approaches for the Pre- diction of Human Drug Absorption Symposium 4: Optimisation of Formulation and
Pharmaceutical Technology Forum: AIDS and Drug Addiction
Tuesday, 7 September 14.00-17.00
Symposium 5: Prediction of Drug Absorption in Man by Animal Experiment
Symposium 6: Changes/Variations far drug Sub- stances and Drug Products
Symposium 7: Sexual Dysfunction: Disease and New Treatment Interventions Forum: Health Promotion (simultaneous
translation)
CPS: Steering Committee (Community Pharmacy Section programme)
Wed.nesday, 8 September 09.00-12.00
Symposium 8: The Impact of the Internet on Phar- macy Practice
Symposium 9: Professional Autonomy - The Di- lemmas of Trading Profession Symposium lO:Impact of Ethnicity in Drug Develop·
ment far the Globe
Forum:
CPS:
Forum:
Assembly of Pharmacists
Oral Communications (Commmıity
Pharmacy Section programme) Biotechnology: from laboratory to patient care
Wed.nesday, 8 September 14.00-17.00
Symposium ll:Position Emission Tomography-State of the Art and Future Development Forum: Quality Pharmacy (simultaneous
translation)
Working Group: Management in the Pharmacy Forum: IPSF Pharmacy Students of Today
are the Pharmacists of Tomorrow Working Group: Managed Care
Thursday, 9 September 09.00-12.00 Symposium 13:Evidence Based Pharmacy Working Group: History of Pharmacy Pi: Pharmacy Information Section
Ethical Issues in the Use and Pro- vision of Information
IPS:
Ethical issues in health care: an over- view
Implications of the pharmacist's ob- ligations in FIP's "Code of Ethics for Pharmacists": case studies
Audience Participation and Panel Discussion Section Business Meeting Industrial Pharmacy Section
FABAD J. Pharm. Sci., 24, 125-127, 1999
Setting Specifications lor Excipients and Drug Substances-Functionality Related Tesis
How can the academia contribute in the development of functionality re- lated tesis?
Can functionality related tesis im- prove the rnanufacturing process?
How does a functionality related test contribute to an improved quality control?
Functiona!ity related tests- Pharmacopoeial aspects
Thursday, 9 September 14.00-17.00 HPS: Hospital Pharmacy Section
Antibiotic therapy, problems with resistance and infection control Chemotherapy-targeting medication drug
MEPS:
MAPS:
Pl:
HIV-treatment and pitfalls
Anticoagulation management control Business meeting: Assessing Com- petency lor Practice
Specialisation - Accreditation Performance Appraisal Credentialing
Military and Emergency Pharmacy Section
Visit to Military Pharmaceutical In- stallations
Medicinal and Aromatic Plants Sec- tion
Approaches to Drug Discovery from Plants
Entheogen plants as a source of bio- active molecules "
The chemotaxonomical approach The ethnopharmacological approach Screening procedures lor biological activity
Pharmacy Information Section Patient Drug Use Information Leaf- lets: Where are we and where are we going?
International comparison of patient drug information resources
CPS:
Patient drug lı.se information in- itiatives iı1 Spain
Comprehension and reca!l in written drug information
Drug information to patients and consumers: developing country per- spectives
lndividualised patient drug in- formation: an overview of recent de- velopments in different countries Community Pharmacy Section Continuing Professional Develop- ment
lmproving Patient Outcomes by Pharmacist Intervention
Outcomes in day-to-day practice
Thursday, Workshops: 15.00-17.00
IPS: lndustrial Pharmacy Section
Similarity Test (f2) far Dissolution Profiles:
CBS:
AS:
OLMCS:
APS:
The Significance in Drug Develop- ment and Post Approval Changes Dissolution profile comparison - 12:
Overview and its apphcations Statistical evaluation of f2 compari- son
lndustry experiences on use of f2 metrics
Other experiences from regulatory agencies
Clinical Biology Section
Education and Training in Clinical Biology in Spain
Antioxidants (Vitamines) in Clinical Biology in Spain
European register for directors of clinical laboratories
Academic Pharmacy Section Poster podium presentation
Teaching and Learning Methodology in Pharmacy
Official Laboratories and Medicines Control Services Section
How to Introduce New Analytical Techniques in the Regulatory Process Administrative Pharmacy Section
125
FABAD J. Pharnı. Sci.. 24, 125-127, 1999
Organisational Culture Influertcin_g the Quality of Drug Use
Treat111erıt culture and behaviour:
conceptual and methodological ap- proeches to infh.ı_e:nce the quality of druguse
Qualitative research in the drug use by children in differenl counlries The elfecl of medication attitude on the safety of administra!ions of med-
icirıes in residential homes
Friday, 10 September 09.00-12.00
HPS: Hospital Pharmacy Section
MEPS:
MAPS:
Pi:
CPS:
!PS:
126
Methods to Prevent Adverse Drug Events
Blood level assessment
Computerisation of compounding Process Control of Prescribing Military and Emergency Pharmacy Section
Medicinal and Aromatic Plants Sec- hon
Pharmacy lnformation Section Current !ssues in Drug and Health Care !nformalion
Providing drug information from the Spanish health adrnirıistralion
Need for international standards for codes and classification systerns The expanding role of US phar- macists in disease management New tedmologies and databases af- feding pharmacy practice
Preventing medication errors: new tools for the pharmacist
Pharmaceutical therapy choice re- view in promoting rational drug use Comrnunity Pharrrıacy Section
!ndustrial Pharmacy Section
Pharn1aco-economics in Osteoporosis
CBS:
AS:
OLMCS:
APS:
Osteoporosis, a disease state?
Models for pharrnaco-economic re- search and pharmaco eco11omic data in osteoporosis?
Pharrnaco-economics and the intro- duclion of new bis-phosphonate Hipprotector and pharrnaco- economics
Clinical Biology Section Academic Pharmacy Section
Quality Assurance in Pharmacy Ed- ucation
Official Laboratories and Medicines Control Services Section
Oral communications
Administrative Pharmacy Section Objective Appraisal of Phar- maceulical Care
What should be done !o evaluate whether Pharmaceutical Care has value for the profession or for the public?
Chances and barriers to irnplernent Pharrnaceu!ical Care into pharmacy practice Pharn1aceutical Care as a challenge for Pharrnacy Praclice Re- search
Should the sickness fund reimburse Pharmaceu tical Care?
Friday, 10 September 14.00-17.00
HPS: Hospital Pharmacy Section
MAPS: Medicinal and Aromatic Plants Section MEPS: Military and Ernergency Pharmacy Section CPS: Comrnunity Pharmacy Section
IPS: lndustrial Pharmacy Section CBS: Clinical Biology Section
